PRECISEU Matchmaking Platform

20 Oct 2025 – 30 Apr 2026 | Barcelona, Spain

Register
Register
Register

Clepio Biotech Srl

Startup

www.clepiobiotech.comRome, Italy
10 profile visits

About

Clepio is a startup company aiming at bringing 3D histology and spatial biology a reality.

Our vision: 2D analysis of biological tissue leads to severe sampling biases, reducing the reliability of information extracted from histology and spatial biology methods. 3D analysis gets rid of all this limitation, enabling a quantum leap in biology and medicine.

Our mission: bring to the market a reliable and scalable solution for 3D analysis of biological tissue, compliant with IVDR and FDA regulations. With our proprietary technology we can finally enable the transition towards a fully-3D histology and spatial biology.

Social media

Type of Cooperation

Research collaborationClinical validationConsortium partners

Development Stage (TRL)

TRL 6

Sector

DiagnosticsOncologyOther

Therapeutic Area

Neoplasms/cancer/oncology

Representatives

CSO

Clepio Biotech Srl

Marketplace (1)

  • Business Opportunity

    3D histological biomarkers for precision medicine

    Our goal is to validate the prognostic and predictive accuracy of histological biomarkers in 3D, exploiting our scalable 3D histology solution. This approach will solve the sampling bias inherent in state-of-the art 2D histological approaches

    • AI
    • TRL 6
    • Oncology
    • Proteomics
    • Diagnostics
    • Clinical validation
    • Consortium partners
    • Neoplasms/cancer/oncology
    Author

    CSO at Clepio Biotech Srl

    Rome, Italy